Federal award (PURCHASE ORDER, fiscal year 2023)
Recipient: SUN PHARMACEUTICAL INDUSTRIES, INC.
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2022-03-10 to 2024-03-11
Current total value of award: $595953.5
Description: NUCLEAR MEDICINE IMAGING PRODUCTS FOR MYOCARDIAL INFARCT IMAGING, DIAGNOSTIC IMAGING OF GALL BLADDER DISORDERS, AND BREAST CANCER NODULE IMAGING MEDICINE.